Company: COPL-UN
Filing Date: 2025-04-01
Form Type: S-1/A
Source: 0001829126-25-002247
Chunk: 33

Company: Copley Acquisition Corp
Filing Date: 2025-04-01
Form: S-1/A
Chunk 33
---
 PRC and the ties of certain of our directors and officers to the PRC, particularly Hong Kong, we may be subject to the uncertainty
of different interpretation and enforcement of the rules and regulations in the PRC adverse to us, which may take place quickly with
little advance notice.

<div align='center'>9</div>

While the application of
the M&A Rules remains unclear, no official guidance and related implementation rules have been issued in relation to the Opinions.
The interpretation and implementation of the Opinions also remains unclear at this stage, based on our understanding of the current PRC
laws and regulations in effect. No prior permission is required under the M&A Rules or the Opinions from any PRC governmental authorities
(including the CSRC) for consummating this offering by the Company. If it is determined in the future that the approval of the CSRC,
the CAC or any other regulatory authority is required for this offering, we or our post-business combination company may face sanctions
by the CSRC, the CAC or other PRC regulatory agencies. The CSRC, the CAC or other PRC regulatory agencies also may take actions requiring
us, or making it advisable for us, to halt this offering before settlement and delivery of our public shares and our public warrants.
Consequently, if you engage in market trading or other activities in anticipation of and prior to settlement and delivery, you do so
at the risk that settlement and delivery may not occur. In addition, if the CSRC, the CAC or other regulatory PRC agencies later promulgate
new rules or explanations requiring that we obtain their permission, licenses or approvals for filings, registrations or other kinds
of authorizations for our initial business combination, we cannot assure you that we can obtain the permission, licenses or approvals,
or complete required procedures or other requirements in a timely manner, or at all, or obtain a waiver of the requisite requirements
if and when procedures are established to obtain such a waiver. Any uncertainties and/or negative publicity regarding such an approval
requirement could have a material adverse effect on the trading price of our securities.

Additionally, on February 17,
2023, the CSRC promulgated the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (the “Trial
Measures”), which took effect on March 31, 2023. The Trial Measures supersede the Draft Rules and clarified and emphasized
several aspects, which include but are not limited to: (1) comprehensive